Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,415 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prediction of Significant Prostate Cancer in Equivocal Magnetic Resonance Imaging Lesions: A High-volume International Multicenter Study.
Sigle A, Borkowetz A, von Hardenberg J, Drerup M, Kornienko K, Kwe J, Wenzel M, Mandel P, Westhoff N, Rieger C, Hoffmann MA, Ortner G, Mahjoub S; GeSRU Academics Prostate Cancer Group. Sigle A, et al. Among authors: mandel p. Eur Urol Focus. 2023 Jul;9(4):606-613. doi: 10.1016/j.euf.2023.01.020. Epub 2023 Feb 17. Eur Urol Focus. 2023. PMID: 36804191
Does Cytoreductive Prostatectomy Really Have an Impact on Prognosis in Prostate Cancer Patients with Low-volume Bone Metastasis? Results from a Prospective Case-Control Study.
Steuber T, Berg KD, Røder MA, Brasso K, Iversen P, Huland H, Tiebel A, Schlomm T, Haese A, Salomon G, Budäus L, Tilki D, Heinzer H, Graefen M, Mandel P. Steuber T, et al. Among authors: mandel p. Eur Urol Focus. 2017 Dec;3(6):646-649. doi: 10.1016/j.euf.2017.06.016. Epub 2017 Jul 8. Eur Urol Focus. 2017. PMID: 28753877
Enumeration and Changes in Circulating Tumor Cells and Their Prognostic Value in Patients Undergoing Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer-Translational Research Results from the Prospective ProMPT trial.
Mandel PC, Huland H, Tiebel A, Haese A, Salomon G, Budäus L, Tilki D, Chun F, Heinzer H, Graefen M, Pantel K, Riethdorf S, Steuber T. Mandel PC, et al. Eur Urol Focus. 2021 Jan;7(1):55-62. doi: 10.1016/j.euf.2019.05.008. Epub 2019 Jun 6. Eur Urol Focus. 2021. PMID: 31178293
Performance of Combined Magnetic Resonance Imaging/Ultrasound Fusion-guided and Systematic Biopsy of the Prostate in Biopsy-naïve Patients and Patients with Prior Biopsies.
Preisser F, Theissen L, Wenzel M, Humke C, Bodelle B, Köllermann J, Kluth L, Banek S, Becker A, Roos F, Chun FK, Mandel P. Preisser F, et al. Among authors: mandel p. Eur Urol Focus. 2021 Jan;7(1):39-46. doi: 10.1016/j.euf.2019.06.015. Epub 2019 Jul 8. Eur Urol Focus. 2021. PMID: 31296485
Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features.
Bernatz S, Ackermann J, Mandel P, Kaltenbach B, Zhdanovich Y, Harter PN, Döring C, Hammerstingl R, Bodelle B, Smith K, Bucher A, Albrecht M, Rosbach N, Basten L, Yel I, Wenzel M, Bankov K, Koch I, Chun FK, Köllermann J, Wild PJ, Vogl TJ. Bernatz S, et al. Among authors: mandel p. Eur Radiol. 2020 Dec;30(12):6757-6769. doi: 10.1007/s00330-020-07064-5. Epub 2020 Jul 16. Eur Radiol. 2020. PMID: 32676784 Free PMC article.
1,415 results